Pharmaceutical - Arena Pharmaceuticals, Research


Popular Filters

Arena Pharma licenses temanogrel to Ildong Pharma for South Korea


The USA's Arena Pharmaceuticals (Nasdaq: ARNA) has entered into a co-development and license agreement…

Arena PharmaceuticalsAsia-PacificCardio-vascularIldong PharmaLicensingPharmaceuticalResearchtemanogrel

Arena files complete response on lorcaserin


In another attempt to gain approval for its obesity drug candidate that was turned down by US regulators…

Arena PharmaceuticalsEisailorcaserinLorquessMetabolicsNorth AmericaPharmaceuticalRegulationResearch

Back to top